The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice.
A 72-year-old woman presents with persistent anemia and fatigue. Her height is 5 ft 2 in and weight is 131 lb (body mass index of 24). She was diagnosed with low- to intermediate-risk myelodysplastic syndrome (MDS) with ring sideroblasts 2 years ago, when she presented with a hemoglobin of 10.9 g/dL. Bone marrow biopsy at the time showed blasts were 5%-7% and she had a normal female karyotype. She tested positive for SF3B1 mutation and negative for JAK2 V617F mutation. The patient received erythropoiesis-stimulating agent (ESA) therapy and required ≥ 2 red blood cell (RBC) units over 8 weeks. However, despite ESA therapy, the patient presents with symptomatic anemia; her hemoglobin is 10.1 g/dL. There are no blasts in the blood; 16% of erythroid precursors with ring sideroblasts are identified.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Emmanuel C. Besa. Skill Checkup: A 72-Year-Old Woman With Myelodysplastic Syndrome Presents With Persistent Anemia and Fatigue - Medscape - Apr 08, 2022.